PyInvesting

Market research

002644.SHE LanZhou Foci Pharmaceutical Co.,Ltd

SHE CNY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
4B
P/E ratio
75.09
Analyst target
Not available
Dividend yield
0.8%
Beta
0.2

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

LanZhou Foci Pharmaceutical Co.,Ltd is currently in a long term uptrend where the price is trading 18.3% above its 200 day moving average.

From a valuation standpoint, the stock is 42.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.5.

LanZhou Foci Pharmaceutical Co.,Ltd's total revenue rose by 11.5% to $174M since the same quarter in the previous year.

Its net income has dropped by 62.8% to $11M since the same quarter in the previous year.

Finally, its free cash flow fell by 188.9% to $-61M since the same quarter in the previous year.

Based on the above factors, LanZhou Foci Pharmaceutical Co.,Ltd gets an overall score of 3/5.